Shilpa Medicare gets USFDA nod for arthritis drug
05 Mar 2021 Capital Market - Live News
Shilpa Medicare has received United States Food and Drug Administration (USFDA)s tentative approval for its abbreviated new drug application (ANDA), apremilast tablets, 10 mg, 20 mg, and 30 mg.